Bedia Jacob S, Huang Ying-Wen, Gonzalez Antonio Delgado, Gonzalez Veronica D, Funingana Ionut-Gabriel, Rahil Zainab, Mike Alyssa, Lowber Alexis, Vias Maria, Ashworth Alan, Brenton James D, Fantl Wendy J
Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
bioRxiv. 2024 Nov 26:2024.11.21.624591. doi: 10.1101/2024.11.21.624591.
Tubo-ovarian high-grade serous carcinoma (HGSC) is the most lethal gynecological malignancy and frequently responds to platinum-based chemotherapy because of common genetic and somatic impairment of DNA damage repair (DDR) pathways. The mechanisms of clinical platinum resistance are diverse and poorly molecularly defined. Consequently, there are no biomarkers or medicines that improve patient outcomes. Herein we use single cell mass cytometry (CyTOF) to systematically evaluate the phosphorylation and abundance of proteins known to participate in the DNA damage response (DDR). Single cell analyses of highly characterized HGSC cell lines that phenocopy human patients show that cells with comparable levels of intranuclear platinum, a proxy for carboplatin uptake, undergo different cell fates. Unsupervised analyses revealed a continuum of DDR responses. Decompositional methods were used to identify eight distinct protein modules of carboplatin resistance and sensitivity at single cell resolution. CyTOF profiling of primary and secondary platinum-resistance patient models shows that a complex DDR sensitivity module is strongly associated with response, suggesting it as a potential tool to clinically characterize complex drug resistance phenotypes.
输卵管卵巢高级别浆液性癌(HGSC)是最致命的妇科恶性肿瘤,由于DNA损伤修复(DDR)途径常见的基因和体细胞损伤,其对铂类化疗常常有反应。临床铂耐药的机制多种多样,且分子层面定义不明确。因此,没有生物标志物或药物能改善患者预后。在此,我们使用单细胞质谱流式细胞术(CyTOF)系统评估已知参与DNA损伤反应(DDR)的蛋白质的磷酸化和丰度。对高度特征化的、模拟人类患者的HGSC细胞系进行单细胞分析表明,具有可比核内铂水平(卡铂摄取的替代指标)的细胞会经历不同的细胞命运。无监督分析揭示了DDR反应的连续性。采用分解方法在单细胞分辨率下识别出八个不同的卡铂耐药和敏感蛋白模块。对原发性和继发性铂耐药患者模型的CyTOF分析表明,一个复杂的DDR敏感模块与反应密切相关,这表明它是临床上表征复杂耐药表型的潜在工具。